PubMed Health⌕ Search

PubMed · 12412944

Standardizing sliding scale insulin orders.

Abstract

The objective of this study was to decrease variation in an inpatient setting in diagnosing and treating patients with a secondary diagnosis of type II diabetes mellitus. Physician ordering practices were reviewed in a 262-bed acute care hospital with 489 physicians on the active medical staff. Using standard quality improvement methodology, the diagnosis of and care of hyperglycemia and type II diabetes mellitus was analyzed and changes in ordering practice recommended. Standardized sliding-scale orders were implemented with widespread staff acceptance as demonstrated by 80% use after 6 months, and over 500 undiagnosed hyperglycemic patients will be counseled in 2001. The costs for the program were more than covered by the estimated annualized savings of 687 bed days and $134,832. This project demonstrates that standardizing care for inpatients with type II diabetes mellitus is possible. The cost savings (not including the value of good will and perceived increase in quality by the patients) justifies the time and effort to make these changes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Richard J Rafoth. Standardizing sliding scale insulin orders.. https://doi.org/10.1177/106286060201700503

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Serum testosterone levels and breast cancer recurrence.

Prospective studies show that high serum levels of androgens and estrogens are associated with increased incidence of postmenopausal breast cancer. The aim of the present analysis was to study the prognostic value of serum testosterone, estradiol and related factors in postmenopausal breast cancer patients. One hundred and ten patients without clinical recurrence were included in the study. After 5.5 years of follow-up, 31 patients developed distant metastasis (16), local relapse (4), or contralateral breast cancer (11). The risk of adverse events in relation to hormone level was examined by Cox' proportional hazard modeling, adjusting for hormone receptor status and stage at diagnosis. Body mass index and serum levels of testosterone, estradiol and glucose were significantly higher in patients who recurred than those who did not. The hazard ratios were 1.8 (95% CI = 0.5-6.3) for the middle and 7.2 (95% CI = 2.4-21.4) for the upper tertiles of baseline testosterone distribution. Other hormones had only minor influence on prognosis. High testosterone predicts breast cancer recurrence. Further studies are required to determine whether dietary or other medical intervention to reduce testosterone can reduce the recurrence of breast cancer.

Blood Glucose↗

Effect of diabetes mellitus and different treatments on plasma and erythrocyte phospholipid fatty acid composition in type 2 diabetics.

AIM: The aim of the present study was to determine how the fatty acid composition of plasma and erythrocyte phospholipids is influenced by the diabetic condition and by dietary or glibenclamide treatment in type 2 diabetes. METHODS: The fatty acid composition of plasma and erythrocyte phospholipids is assessed in 3 nonobese groups of Cuban diabetics with comparable age and BMI: 13 newly diagnosed, 15 on diet alone and 15 on diet/glibenclamide. Thirteen healthy individuals were used as controls. Fasting serum glucose, insulin and glycosylated hemoglobin and dietary fat intake were assessed. RESULTS: In plasma phospholipids, significant lower values were found for 14:0, 15:0 and 17:0 in newly diagnosed patients than in controls. In red blood cell phospholipids, 14:1, 20:0 and 24:1 of newly diagnosed patients were significantly lower than of controls, and 16:1omega7 and 18:4omega3 were significantly higher. The different treatments had an effect on 18:0, 18:1t, 20:0 and total trans fatty acids in erythrocyte, but not in plasma phospholipids. CONCLUSIONS: Changes in plasma phospholipid fatty acids found in type 2 diabetics may be due to an 'adapted' dietary pattern, whereas those in erythrocyte phospholipids may be attributed to effects of the disease itself and may be susceptible to normalization by diet or glibenclamide.

Blood Glucose↗